Spectral Medical Inc. EDTXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -23.64% | 62.95% | -40.54% | 33.14% | 70.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -23.64% | 62.95% | -40.54% | 33.14% | 70.71% |
| Cost of Revenue | 18.88% | 17.58% | -42.63% | -7.98% | -41.52% |
| Gross Profit | -47.34% | 102.73% | -37.92% | 162.80% | 2,566.01% |
| SG&A Expenses | -20.63% | 2.13% | -12.15% | 3.07% | -27.78% |
| Depreciation & Amortization | 57.45% | 9.44% | 43.01% | 2.94% | -95.10% |
| Other Operating Expenses | 22.82% | -9.49% | 170.98% | -72.05% | -- |
| Total Operating Expenses | -15.67% | 3.02% | -12.58% | -1.65% | -35.18% |
| Operating Income | 12.99% | 6.47% | 5.37% | 7.51% | 46.38% |
| Income Before Tax | 117.11% | 75.63% | -190.20% | -200.36% | 56.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 117.11% | 75.63% | -190.20% | -200.36% | 56.57% |
| Earnings from Discontinued Operations | -- | -4.76% | 100.00% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 117.11% | 75.62% | -190.32% | -200.36% | 56.57% |
| EBIT | 12.99% | 6.47% | 5.37% | 7.51% | 46.38% |
| EBITDA | 13.34% | 6.65% | 5.56% | 7.78% | 46.55% |
| EPS Basic | 116.33% | 76.30% | -188.61% | -195.00% | 57.39% |
| Normalized Basic EPS | 116.13% | 76.17% | -188.00% | -193.87% | 56.94% |
| EPS Diluted | 116.33% | 76.30% | -188.61% | -195.00% | 57.39% |
| Normalized Diluted EPS | 116.13% | 76.17% | -188.00% | -193.87% | 56.94% |
| Average Basic Shares Outstanding | 2.99% | 2.98% | 2.91% | 1.87% | 1.73% |
| Average Diluted Shares Outstanding | 2.99% | 2.98% | 2.91% | 1.87% | 1.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |